Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Capital Financing
Perspectives and future directions for epigenetics in hematology.
Gagging
Disseminated intravascular multiple systems activation (DIMSA) following thermal injury.
AKT is a therapeutic target in myeloproliferative neoplasms.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
AKT is a therapeutic target in myeloproliferative neoplasms.
AKT is a therapeutic target in myeloproliferative neoplasms. Leukemia. 2013 Sep; 27(9):1882-90.
View in:
PubMed
subject areas
Animals
Apoptosis
Bone Marrow
Cell Cycle Checkpoints
Cell Line
Cell Proliferation
Disease Models, Animal
Female
Fusion Proteins, bcr-abl
Heterocyclic Compounds, 3-Ring
Humans
Janus Kinase 2
Liver
Megakaryocytes
Mice
Mutation
Myeloproliferative Disorders
Neoplastic Stem Cells
Phosphorylation
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-akt
Signal Transduction
Spleen
authors with profiles
Sandeep Gurbuxani